financetom
Market
financetom
/
Market
/
US STOCKS-S&P 500, Nasdaq muted as investors await Mideast peace deal progress
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US STOCKS-S&P 500, Nasdaq muted as investors await Mideast peace deal progress
May 27, 2026 9:50 AM

* Indexes: Dow up 0.42%, S&P 500 flat, Nasdaq down 0.15%

* GlobalFoundries ( GFS ) falls on report of Mubadala share sale

* Zscaler ( ZS ) plunges after downbeat Q4 forecast

* Goldman Sachs ( GS ) lifts S&P 500 year-end forecast to 8,000

(Updates with analyst comment, prices)

By Twesha Dikshit and Utkarsh Hathi

May 27 (Reuters) - The S&P 500 and the Nasdaq were muted

on Wednesday in choppy trading, as investors remained cautious

while awaiting progress in Middle East talks.

White House denied reports from Iran's state TV that said

Tehran would restore Strait of Hormuz shipping within a month in

exchange for a U.S. military pullback and lifting of a naval

blockade.

Still, indexes traded near record highs. The Dow Jones

nudged higher, lifted by a rotation into healthcare and consumer

stocks. However, a pullback in chip stocks weighed on the

tech-heavy Nasdaq.

"After such a large run-up in the markets, it's not

surprising to me that there is a little bit of a pause," said

Sean Clark, chief investment officer of Clark Capital Management

Group.

"There's a lot of positives to look at right now. Even

though the outperformers are really being driven by tech, AI and

AI adjacent themes, I wouldn't discount the fact that the broad

market is participating as well."

At 11:35 a.m. ET, the Dow Jones Industrial Average

rose 212.62 points, or 0.42%, to 50,674.30, the S&P 500

lost 3.67 points, or 0.05%, to 7,515.45 and the Nasdaq Composite

lost 39.32 points, or 0.15%, to 26,616.86.

Seven of the 11 main S&P 500 sectors were in the positive

territory, with consumer discretionary leading the

gains, up almost 2%.

The healthcare index rose 0.7%, while consumer

staples added 1.5%.

Meanwhile, the S&P 500 energy index fell 1.2%,

tracking a decline of as much as 5% in oil prices. Tech shares

shed 1% after reaching an all-time high on Tuesday.

Chip stocks were down after a strong rally. Intel ( INTC )

and Marvell Technology ( MRVL ) fell over 4% each, while

Qualcomm shed 9.2%.

The Philadelphia SE Semiconductor index lost 2.7%,

with chip giant Nvidia ( NVDA ) off 2.3%.

Zscaler ( ZS ) tumbled 31% after the cloud security firm

projected fourth-quarter revenue below expectations.

JPMorgan shares dropped 3.3% after CEO Jamie Dimon

said expenses for the year could be $1 billion higher than

earlier estimates. The declines pressured the financials index.

Among other movers, GlobalFoundries ( GFS ) fell 11.6% after

Bloomberg News reported that majority owner Mubadala Investment

Company was seeking to raise $1.91 billion from an unregistered

block sale of GFS shares.

Bath & Body Works ( BBWI ) jumped 12.3% after reporting

first-quarter sales and profit above expectations, while

Abercrombie and Fitch ( ANF ) advanced 11.3% on posting a strong

quarterly profit.

EARNINGS DRIVE MARKETS, DATA AWAITED

A strong earnings season and expectations of about 29%

year-on-year growth in the first quarter have aided the rally on

Wall Street.

Goldman Sachs ( GS ) raised its 2026 year-end forecast for the S&P

500 to 8,000 from 7,600, citing continued strength in corporate

earnings.

Markets will next look toward the personal consumption

expenditures index data on Thursday. The Federal Reserve's key

inflation measure could provide fresh clues on the monetary

policy path forward under new chair Kevin Warsh.

Advancing issues outnumbered decliners by a 1.4-to-1 ratio

on the NYSE and by a 1.24-to-1 ratio on the Nasdaq.

The S&P 500 posted 36 new 52-week highs and 6 new lows,

while the Nasdaq Composite recorded 139 new highs and 52 new

lows.

(Reporting by Twesha Dikshit and Utkarsh Hathi; Editing by

Shinjini Ganguli and Joyjeet Das)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Financial
Sector Update: Financial
Mar 21, 2024
03:19 PM EDT, 03/21/2024 (MT Newswires) -- Financial stocks advanced late Thursday afternoon, with the NYSE Financial Index and the Financial Select Sector SPDR Fund (XLF) each rising 0.9%. The Philadelphia Housing Index climbed 1.8%, and the Real Estate Select Sector SPDR Fund (XLRE) was adding 0.4% Bitcoin (BTC-USD) dropped 4% to $65,176, and the yield for 10-year US Treasuries...
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Mar 22, 2024
(Updates to closing prices) TOKYO, March 22 (Reuters) - Japan's Nikkei share average closed at an all-time high on Friday, underpinned by record gains on Wall Street overnight and strength in automakers' stocks on a weaker yen. The Nikkei rose 0.18% to end at 40,888.43, after hitting 41,087.75 earlier in the session to break an all-time intraday high. The index,...
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Mar 21, 2024
TOKYO, March 22 (Reuters) - Japan's Nikkei share average hit a record high on Friday, underpinned by the strength on Wall Street overnight and as a weaker yen prompted investors to buy automakers. The Nikkei rose to as high as 41,087.75 earlier in the session, crossing the 41,000 level for the first time. The index ended 0.07% higher at 40,844.53...
Sector Update: Health Care
Sector Update: Health Care
Mar 21, 2024
03:42 PM EDT, 03/21/2024 (MT Newswires) -- Health care stocks rose late Thursday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) rising 0.3%. The iShares Biotechnology ETF (IBB) climbed 0.9%. In corporate news, Eledon Pharmaceuticals ( ELDN ) shares surged 12% after it said its tegoprubart monoclonal antibody was used...
Copyright 2023-2026 - www.financetom.com All Rights Reserved